EUTM file information

018499517

ADAC

June 22, 2021

Trademark Summary

The trademark ADAC was filed by Strike Pharma AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on July 22, 2021, and received one opposition filed on October 24, 2021 by Heidelberg Pharma Research GmbH on Likelihood of confusion. the opponent was represented by DIE PATENTERIE GBR and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 24, 2021

It was designated 'Basic Application' for International Application 1617394 at the World Intellectual Property Organization (WIPO).

The application was filed in Swedish, and Swedish was also language of all opposition proceedings (English was selected as the second language).

Change of name and address of the trademark registration was recorded on November 22, 2021. Change of name and professional address of the trademark registration was recorded on July 14, 2022.

Goods And Services

  • The mark was filed in class 1 with Chemicals for production of antibodies and synthetic and natural peptides.
  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations for human use
    2. Veterinary preparations
    3. Vaccins
    4. Therapeutic medicines
    5. Pharmaceutical preparations for the treatment of diseases and conditions in the areas of immunology, oncology, immuno-oncology
    6. Diabetes, autoimmunology, dermatology, gynecology, urology and gastroenterology
    7. Antibodies
    8. None of the aforementioned for use in relation with ocular, peri-ocular and sight fields.
  • The mark was filed in class 10 with following description of goods:
    1. Delivery systems for the deferred, controlled or immediate release of active substances of pharmaceutical preparations
    2. Inhalers
    3. Syringes for injection and medical purposes
    4. None of the aforementioned for use in relation with ocular, peri-ocular and sight fields.
  • The mark was filed in class 42 with following description of goods:
    1. Research and development within the biological, pharmacological, veterinary, microbiological, biomedical, pharmabiotical, biotherapeutical and biotechnological areas
    2. Research and development of a synthetic antibody library including methods for selection and screening of such
    3. Research and devepment in the area of personalized medicine
    4. Laboratory services related to production of antibodies
    5. Research and development in the area of antibodies.
Trademarkers